CDEK
← All organizations

Xanodyne Pharmaceuticals

For profitContributed to NME

Also known as: Xanodyne | XANODYNE PHARM | XANODYNE PHARMS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Aug 1, 2006

First marketed drug

Jan 1, 2000

Last known activity

Jun 1, 2010

Acquired by Assertio on Jan 1, 2012

Timeline

1950s

  1. Aug 16, 1957

    propoxyphene— NDA Secondary Org

1970s

  1. Sep 9, 1971

    propoxyphene— NDA Organization

  2. Dec 19, 1972

    acetaminophen— Marketing Organization

2000s

  1. Jan 1, 2000

    Xanodyne Pharmaceuticals— Founded

2010s

  1. Jan 1, 2012

    Assertio— Acquired By

Drugs by trial phase (3 distinct, 5 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (6)

Recent trials (6)

Details

Founded
Newport, KY, US Jan 1, 2000
Last known activity
Jun 1, 2010

Designations held

  • Priority review

Notes

Acquired by DepoMed 21 Jun 2012